Information date: 28 September 2026 — Under the Foreign Investment Law and the national negative list, foreign investors can choose a wholly foreign-owned enterprise (WFOE), an equity or contractual joint venture (JV), or a representative office (RO). Each structure differs in registered capital, legal liability, business scope, invoicing rights, hiring, tax treatment, and exit options. The negative list still restricts certain sectors. Knowing that statement is not enough for an operating, research or compliance decision. The team must first establish who and what it applies to, how the effect reaches the real process, and which evidence would justify action.
Verified facts and scope
Under the Foreign Investment Law and the national negative list, foreign investors can choose a wholly foreign-owned enterprise (WFOE), an equity or contractual joint venture (JV), or a representative office (RO). Each structure differs in registered capital, legal liability, business scope, invoicing rights, hiring, tax treatment, and exit options. The negative list still restricts certain sectors.
Before choosing, confirm the sector negative list, city and district rules, registered capital and paid-in timeline, business scope wording, whether the entity must generate revenue, hiring and social insurance plans, import-export rights, data processing, and whether a local partner or licence is required.
How the effect reaches operations
A WFOE gives control but requires capital, accounting, and compliance. A JV shares control and risk but can secure a licence or distribution. An RO cannot earn revenue or invoice, so it suits liaison and market research only. Tax, liability, and exit outcomes follow from these legal differences.
Common mistakes include assuming a WFOE is always fastest, using an RO for revenue work, undercapitalising, setting business scope too narrowly, ignoring district practice, and signing a JV without governance or exit clauses. These errors can block hiring, invoicing, or profit repatriation.
For “WFOE vs Joint Venture vs Representative Office in China: Setup Comparison”, official rules or published findings, direct evidence from the relevant product or process, and assumptions that remain untested should be recorded separately. A broad source defines the external boundary; it does not replace batch records, protocols, contracts, labels or direct observations.
Decision
If you need revenue, control, and hiring, use a WFOE. If a local licence or partner is essential, use a JV with clear governance. If you only need liaison or research, use an RO. Always check the negative list first; if the sector is restricted, restructure or seek approval before registering.
Implementation checklist
- Check the negative list and district rules before choosing.
- Model capital, tax, control, and exit for each structure.
- Confirm business scope wording with the local AMR.
- Assign one decision owner, one implementation owner and a dated review point for “WFOE vs Joint Venture vs Representative Office in China: Setup Comparison”.
- For “WFOE vs Joint Venture vs Representative Office in China: Setup Comparison”, archive the source page, access date, applicable population or entity, and internal evidence both supporting and opposing the current decision.
- When a rule, formulation, supplier, protocol or observed result changes, reopen only the affected question in “WFOE vs Joint Venture vs Representative Office in China: Setup Comparison”.
Evidence and review
For “WFOE vs Joint Venture vs Representative Office in China: Setup Comparison”, start with one real case rather than an abstract checklist. Record the input version, responsible owner, start time, observed result and stop condition. If the team cannot complete “Check the negative list and district rules before choosing.” with current evidence, it should not expand the process to more products, patients, suppliers or markets. The first review should focus only on facts capable of changing the decision.
The second control follows “Model capital, tax, control, and exit for each structure.”. Keep the source date, applicable population or entity, deadline, cost effect and owner in the same evidence file. A wording preference does not justify a new version. A repeated discrepancy, an unsupported health claim or a regulatory mismatch does: correct that point and hold release until the evidence is available.
After “Confirm business scope wording with the local AMR.”, compare the intended outcome with what actually happened. Apply the same success criteria to each later expansion. If only one number, date or responsibility changes, update that field and the affected conclusion instead of recreating evidence that remains valid. This keeps the decision traceable without turning review into an open-ended rewrite cycle.
Limits of the conclusion
This comparison is general information, not legal, tax, or investment advice. Rules vary by sector, province, and district, and should be verified with local authorities and qualified advisers before filing.
